Anyone used a compounding pharmacy that takes insurance? — my results so far

the point above about having a transition plan is critical. Here's what I'm doing to prepare: 1. Building a relationship with my PCP to have a prescription pathway to branded Ozempic/Wegovy if needed. Prior authorizations can take weeks, so I want this process started BEFORE I need it. 2. Understanding my insurance coverage for branded GLP-1s. Many plans now cover them for diabetes (T2DM) and increasingly for obesity. The landscape is changing. 3. Saving money now for the potential transition period. Branded GLP-1s cost $800-1400/month without insurance. Even with insurance, copays can be $25-500/month depending on your plan. 4. Staying informed on the FDA's shortage list updates. You can sign up for alerts on the FDA website when specific drugs are added to or removed from the shortage list. 5. Not stockpiling. It's tempting to order extra compounded sema "just in case," but peptides have limited shelf life and stockpiling contributes to supply constraints for everyone.

Super helpful perspective from all angles. The transition plan idea is something I hadn't thought about. I've been so focused on the present that I haven't planned for the possibility of losing access to compounded sema. Any recommendations on which 503B facilities are handling the demand best right now? Not asking for specific pharmacy names if that's against rules, but what characteristics should I look for?

I won't name competitors, but here are characteristics of 503B facilities that are handling the demand responsibly: Green flags: - Transparent about lead times (telling you 14 days and delivering in 14 is better than promising 3 days and delivering in 10) - Still performing full testing on every batch - Willing to provide CoAs without you having to beg - Not dramatically cutting prices (if they're significantly cheaper than 6 months ago, ask why — are they cutting testing?) - Still responsive to quality questions - Have been in the compounding business for >3 years (pre-GLP-1 boom) - PCAB accreditation or other voluntary quality certifications Red flags: - Brand new 503B that registered specifically to compound GLP-1s - Aggressive social media marketing and influencer partnerships - Rock-bottom pricing that seems too good to be true - Unable to provide CoAs or slow to respond to quality questions - No transparency about lead times or supply constraints - Pressure tactics ("order now, supply is limited!") - No evidence of compounding other sterile products (suggests they lack general sterile compounding expertise) The best pharmacies are the ones that were doing high-quality sterile compounding BEFORE the GLP-1 boom and have scaled responsibly to meet new demand. They have the foundational expertise, the quality culture, and the infrastructure. They may cost a bit more and have longer lead times, but the product quality is worth it.

Excellent thread. Summary for my own reference: - Demand is massively outpacing supply even at 503B level - Quality-focused facilities are scaling carefully, which means longer lead times - New entrants should be heavily vetted - The shortage ending could disrupt compounded access — have a transition plan - Pay attention to the FDA shortage list updates - Quality indicators matter more during high-demand periods, not less Thanks everyone. This community consistently provides better analysis than anything I've read in mainstream media.